These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5412616)

  • 1. [3 years of experience with treatment of some arrhythmias with Ritmos (ajmaline)].
    Apostolov L; Batalov Z; Mironov P; Panitsa D
    Minerva Med; 1970 Jan; 61(5):121-7. PubMed ID: 5412616
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of 17,21-di-monochloroacetyl-ajmaline in the prevention and therapy of arrhythmia caused by myocardial hyperexcitability].
    Bossi M; Botti G; Campus S; Cardini A; Cherchi A; Coljca A; Di Benedetto A; Folli G; Franzosi P; Geraci E; Lampertico M; Lotto A; Magnani B; Modica G; Selvini A; Serio G; Visioli O
    Minerva Med; 1970 Jan; 61(5):113-20. PubMed ID: 4189651
    [No Abstract]   [Full Text] [Related]  

  • 3. [Di-mono-chloracetyl-ajmaline in the treatment of cardiac rhythm disorders].
    Bucour V; Enesco R; Sirbulesco R; Pompilian P
    Minerva Med; 1970 Jan; 61(5):128-35. PubMed ID: 4189652
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of DCAA (Ritmos Elle) in hospital practice in grave arrhythmias].
    De Michelis S; Paparella P; Seu V
    Minerva Med; 1970 Jan; 61(5):136-49. PubMed ID: 4189653
    [No Abstract]   [Full Text] [Related]  

  • 5. [On ajmaline treatment of heart rhythm disorders].
    Forster G; Holzmann M
    Schweiz Med Wochenschr; 1967 Feb; 97(6):185-93 contd. PubMed ID: 4174226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ajmaline treatment of supraventricular paroxysmal tachycardia in Wolff-Parkinson-White syndrome. Report of a neonatal case].
    Marcer V; Dander B; Spinosa G; Buonanno C
    Minerva Pediatr; 1976 Mar; 28(11):695-700. PubMed ID: 995079
    [No Abstract]   [Full Text] [Related]  

  • 7. [3-Year experience in the treatment with several arrhythmias with ritmos (ajmalin)].
    Apostolov L; Batalov Z; Mironov P; Panitsa D
    Kardiologiia; 1968 Nov; 8(11):82-9. PubMed ID: 4184833
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oral action of N-propyl-ajmaline bitartrate. I. Preliminary note].
    Martínez-Muñoz A
    Rev Esp Cardiol; 1970 Jun; 23(2):331-40. PubMed ID: 5518738
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiarrhythmic efficacy of mexiletine in supraventricular arrhythmias, Wolff-Parkinson-White syndrome and persistent iterative ventricular hyperkinetic arrhythmias. Considerations on these less noted therapeutic effects].
    Menozzi C; Lolli G; Monducci I; Gheller G; Brignole M; Cattabiani ML; Vergoni W; Barone A
    Clin Ter; 1984 Feb; 108(3):199-208. PubMed ID: 6232057
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of ajmalin (gylurritmal) in the treatment of a paroxysmal auricular fibrillation lasting for 3 weeks in a case of W.P.W].
    Duclós F
    Rev Esp Cardiol; 1969; 22(2):240-54. PubMed ID: 5801961
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of dichloroacetyl-ajmaline in cardiac arrhythmias in patients with chronic pneumopathies].
    Vittore F; Bossa P; Rognone L; Balderi C
    Minerva Med; 1970 Jan; 61(5):157-61. PubMed ID: 5412617
    [No Abstract]   [Full Text] [Related]  

  • 12. [Wolff-Parkinson-White syndrome and paroxysmal tachycardia in infants. (Apropos of a case)].
    Guerricchio G
    Minerva Cardioangiol; 1972 Jan; 20(1):27-32. PubMed ID: 5060005
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical observations on the effects of di-monochloracetyl-ajmaline].
    Sperandeo V; Di Benedetto A; Mendola R
    Minerva Med; 1970 Jan; 61(5):150-6. PubMed ID: 4189654
    [No Abstract]   [Full Text] [Related]  

  • 14. [Amiodarone, a class 3 antiarrhythmic agent: current electrophysiological and therapeutic aspects].
    Depelchin P; Schoenfeld P; Stoupel E; Degré S
    Rev Med Brux; 1986 Feb; 7(2):92-103. PubMed ID: 3515481
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-arrhythmic therapy with calcium antagonists].
    Seipel L; Breithardt G; Borggrefe M
    Internist (Berl); 1983 Jul; 24(7):415-21. PubMed ID: 6350211
    [No Abstract]   [Full Text] [Related]  

  • 16. [Digitalization of the arrhythmic heart patient].
    Galassi A; Mangiameli S; Circo A
    Minerva Med; 1981 Jul; 72(29):1945-9. PubMed ID: 7254641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On some special clinical indications of beta-blocking agents].
    Pretolani E
    Cardiol Prat; 1969 Apr; 20(2):115-24. PubMed ID: 5794979
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ajmaline bitartrate in arrhythmias].
    Szoenberg A; Samuel R; Friedman J; Sklerovsky S
    Harefuah; 1974 Jan; 86(2):70-5. PubMed ID: 4133115
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with propafenone in paroxysmal supraventricular reciprocating tachycardias].
    Furlanello F; Vergara G; Dal Forno P; Disertori M; Inama G
    G Ital Cardiol; 1984 May; 14(5):379-80. PubMed ID: 6468821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of life threatening cardiac arrhythmias.
    Schwartz KM; MacLean WA; Waldo AL
    Cardiovasc Clin; 1981; 11(3):25-48. PubMed ID: 7011556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.